2. Wilson C, Canning P, Caravati EM. The abuse potential of propofol. Clin Toxicol (Phila) 2010;48:165-170.
3. Park JH, Kim HJ, Seo JS. Medicolegal review of deaths related to propofol administration: analysis of 36 autopsied cases. Korean J Leg Med 2012;36:56-62.
4. Jung YJ. The number of doctors arrested for drug-related of-fences increased by 64%. The Munwha Ilbo 2012;08. 14.
6. Trapani G, Altomare C, Liso G, Sanna E, Biggio G. Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 2000;7:249-271.
7. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 1998;53:530-538.
8. Lee YS. Pharmacokinetics and pharmacodynamics of drugs for sedation. J Korean Med Assoc 2013;56:279-284.
9. Lee JW, Lee KY. Safe sedation in a private clinic. J Korean Med Assoc 2011;54:1179-1188.
11. Pain L, Gobaille S, Schleef C, Aunis D, Oberling P. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg 2002;95:915-919.
12. Keita H, Lecharny JB, Henzel D, Desmonts JM, Mantz J. Is inhibition of dopamine uptake relevant to the hypnotic action of i.v. anaesthetics? Br J Anaesth 1996;77:254-256.
13. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol 2007;21:459-466.
17. Weerts EM, Ator NA, Griffiths RR. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug Alcohol Depend 1999;57:51-60.
18. Zacny JP, Lichtor JL, Thompson W, Apfelbaum JL. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg 1993;77:544-552.
20. Baldisseri MR. Impaired healthcare professional. Crit Care Med 2007;35:2 Suppl. S106-S116.
21. Hughes PH, Brandenburg N, Baldwin DC Jr, Storr CL, Williams KM, Anthony JC, Sheehan DV. Prevalence of substance use among US physicians. JAMA 1992;267:2333-2339.
22. Beaujouan L, Czernichow S, Pourriat JL, Bonnet F. Prevalence and risk factors for substance abuse and dependence among anaesthetists: a national survey. Ann Fr Anesth Reanim 2005;24:471-479.
23. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, Henthorn TK. A survey of propofol abuse in academic anesthesia programs. Anesth Analg 2007;105:1066-1071.
24. Hong SH. Drug abuse associated with procedural sedation. J Korean Med Assoc 2013;56:292-298.
25. Stocks G. Abuse of propofol by anesthesia providers: the case for re-classification as a controlled substance. J Addict Nurs 2011;22:57-62.
26. Lee S, Lee MS, Kim YA, Ahn W, Lee HC. Propofol abuse of the medical personnel in operation room in Korea. Korean J Leg Med 2010;34:101-107.
27. Kintz P, Villain M, Dumestre V, Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int 2005;153:81-84.
28. Kim JH. Sharp increase in propofol thefts. Health Korea News 2012;10. 11.
29. Domino KB, Hornbein TF, Polissar NL, Renner G, Johnson J, Alberti S, Hankes L. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005;293:1453-1460.